The Future of TAVR | SMART Trial 3-Year Results

Content & Learning Objectives

WEBINAR SERIES

JUST RELEASED. STILL SUPERIOR.

Key Topics

Analyze the key outcomes of the SMART Trial and determine what they mean for patients.

Understand bioprosthetic valve dysfunction (BVD), Prosthesis-patient mismatch (PPM), and thrombosis.

Outline considerations for small annuli patients (<430 mm²) and women.

How these results impact real-world pre-case planning and patient selection.

Learning Objectives

01Outline definitions and types of BVD, preventative strategies, and implications.

02Translate trial results into real-world clinical practice.

03Understand how pre-case planning, imaging, and tools can support patient selection.

04Identify indicators of low-flow, low-gradient severe aortic stenosis.

Session II

Faculty

5 Speakers

MODMatthew Summers, MD

SPKHoward C. Herrmann, MD | Zarina Sharalaya, MD | Matthew Summers, MD | Kelly C. Epps-Anderson, MD | Craig Basman, MD, FACC, FSCAI

Program Agenda

56 MIN7 ITEMS

INTRO

TALK

CASE

DISCUSS

DATA

Q&A

Session Timeline56 min total

7:00 PM7:56 PM

7:00 PM5 min

Welcome & Introduction

Matthew Summers, MD

7:05 PM15 min

SMART Trial 3-Year Results

Howard C. Herrmann, MD

7:20 PM6 min

Discussion

All Faculty

7:26 PM12 min

Women and AS, Thrombosis Impact

Kelly C. Epps-Anderson, MD

7:38 PM12 min

Applying results of the SMART Trial into clinical practice

Zarina Sharalaya, MD

7:50 PM6 min

Discussion

All Faculty

7:56 PM

Live Q&A and Panel

All Faculty

1x INTRO

2x DATA

2x DISCUSS

1x TALK

1x Q&A

CLICK ROW TO EXPAND

Registration

LIVE SERIES

22DAYS

Next sessionSession IIJun 17, 2026 · 00:00 EST

On Demand Materials

THE FUTURE OF TAVR

SMART Evolut 26 FX+

On Demand

SMART Evolut 29 FX+

On Demand

SMART Evolut FX+

On Demand

SMART Evolut 29 FX+ II

On Demand

Support

CONTACT

Still have questions?

Send us a message and we'll get back to you.

The Future of TAVR:3-Year SMART Trial Results